Fate Therapeutics Depreciation & Amortization 2011-2026 | FATE

Annual Depreciation & Amortization Fate Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
12.9 M	19 M	18.3 M	13.8 M	5.85 M	3.09 M	2.19 M	1.2 M	971 K	881 K	687 K	496 K	571 K	590 K	672 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
19 M	496 K	5.41 M

Quarterly Depreciation & Amortization Fate Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.92 M	-	-	3.33 M	-	-	-	4.82 M	-	-	-	4.19 M	-	8.92 M	-	2.76 M	-	3.64 M	-	959 K	-	2.23 M	1.45 M	705 K	-	1.57 M	983 K	440 K	-	877 K	567 K	286 K	-	681 K	437 K	206 K	-	678 K	460 K	227 K	-	477 K	290 K	128 K	-	371 K	256 K	123 K	-	442 K	302 K	157 K	-	430 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.92 M	123 K	1.4 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.14	0.32 %	$ 653 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 35.15	2.03 %	$ 946 M	USA
Forte Biosciences FBRX	64 K	$ 21.07	3.73 %	$ 273 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.65	1.81 %	$ 439 M	Britain
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	2.31 M	$ 0.86	1.44 %	$ 143 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Incyte Corporation INCY	93.3 M	$ 96.77	-0.32 %	$ 18.9 B	USA
Compugen Ltd. CGEN	475 K	$ 2.6	-4.07 %	$ 243 M	Israel
Ionis Pharmaceuticals IONS	10 M	$ 75.11	0.07 %	$ 12 B	USA
Anika Therapeutics ANIK	5.37 M	$ 14.99	-0.99 %	$ 215 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.29	-0.98 %	$ 5.42 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.54	1.99 %	$ 180 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 20.65	0.85 %	$ 2.63 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA